Law360, New York (January 31, 2012, 12:39 PM ET) -- Private equity firm Avista Capital Partners has agreed to sell medical device maker Navilyst Medical to AngioDynamics Inc. for $372 million in cash and stock, the companies announced Tuesday.
New York-based AngioDynamics said it would fund the transaction, based on Monday's per-share closing price of $14.20, with approximately $97 million in cash on hand and $150 million from a fully committed bank financing facility of debt and new common stock from JPMorgan Chase & Co, Bank of America NA and KeyBank National Association, which is owned...
Cadwalader Aids AngioDynamics In $372M Device Maker Buy
To view the full article, take a free trial now.
